Literature DB >> 15383561

Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.

Zhanju Liu1, Leo Lefrançois.   

Abstract

Intestinal autoimmune diseases are thought to be associated with a breakdown in tolerance, leading to mucosal lymphocyte activation perhaps as a result of encounter with bacterium-derived Ag. To study mucosal CD8(+) T cell activation, tolerance, and polarization of autoimmune reactivity to self-Ag, we developed a novel (Fabpl(4x at -132)-OVA) transgenic mouse model expressing a truncated form of OVA in intestinal epithelia of the terminal ileum and colon. We found that OVA-specific CD8(+) T cells were partially tolerant to intestinal epithelium-derived OVA, because oral infection with Listeria monocytogenes-encoding OVA did not elicit an endogenous OVA-specific MHC class I tetramer(+)CD8(+) T cell response and IFN-gamma-, IL-4-, and IL-5-secreting T cells were decreased in the Peyer's patches, mesenteric lymph nodes, and intestinal mucosa of transgenic mice. Adoptive transfer of OVA-specific CD8(+) (OT-I) T cells resulted in their preferential expansion in the Peyer's patches and mesenteric lymph nodes and subsequently in the epithelia and lamina propria but failed to cause mucosal inflammation. Thus, CFSE-labeled OT-I cells greatly proliferated in these tissues by 5 days posttransfer. Strikingly, OT-I cell-transferred Fabpl(4x at -132)-OVA transgenic mice underwent a transient weight loss and developed a CD8(+) T cell-mediated acute enterocolitis 5 days after oral L. monocytogenes-encoding OVA infection. These findings indicate that intestinal epithelium-derived "self-Ag" gains access to the mucosal immune system, leading to Ag-specific T cell activation and clonal deletion. However, when Ag is presented in the context of bacterial infection, the associated inflammatory signals drive Ag-specific CD8(+) T cells to mediate intestinal immunopathology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383561     DOI: 10.4049/jimmunol.173.7.4324

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.

Authors:  Adam E Snook; Michael S Magee; Glen P Marszalowicz; Stephanie Schulz; Scott A Waldman
Journal:  Cancer Immunol Immunother       Date:  2011-11-06       Impact factor: 6.968

2.  Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.

Authors:  Maria Paula Roberti; Satoru Yonekura; Connie P M Duong; Marion Picard; Gladys Ferrere; Maryam Tidjani Alou; Conrad Rauber; Valerio Iebba; Christian H K Lehmann; Lukas Amon; Diana Dudziak; Lisa Derosa; Bertrand Routy; Caroline Flament; Corentin Richard; Romain Daillère; Aurélie Fluckiger; Isabelle Van Seuningen; Mathias Chamaillard; Audrey Vincent; Stephanie Kourula; Paule Opolon; Pierre Ly; Eugénie Pizzato; Sonia Becharef; Juliette Paillet; Christophe Klein; Florence Marliot; Filippo Pietrantonio; Stéphane Benoist; Jean-Yves Scoazec; Peggy Dartigues; Antoine Hollebecque; David Malka; Franck Pagès; Jérôme Galon; Ivo Gomperts Boneca; Patricia Lepage; Bernard Ryffel; Didier Raoult; Alexander Eggermont; Tom Vanden Berghe; François Ghiringhelli; Peter Vandenabeele; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2020-05-25       Impact factor: 53.440

3.  Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.

Authors:  Wujiang Liu; David P Evanoff; Xiaohong Chen; Yi Luo
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

4.  Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin.

Authors:  Clare L Bennett; Farnaz Fallah-Arani; Thomas Conlan; Celine Trouillet; Hugh Goold; Laurent Chorro; Barry Flutter; Terry K Means; Frédéric Geissmann; Ronjon Chakraverty
Journal:  Blood       Date:  2011-05-12       Impact factor: 22.113

5.  Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation.

Authors:  Jarish N Cohen; Cynthia J Guidi; Eric F Tewalt; Hui Qiao; Sherin J Rouhani; Alanna Ruddell; Andrew G Farr; Kenneth S Tung; Victor H Engelhard
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

6.  Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.

Authors:  Adam E Snook; Peng Li; Benjamin J Stafford; Elizabeth J Faul; Lan Huang; Ruth C Birbe; Alessandro Bombonati; Stephanie Schulz; Matthias J Schnell; Laurence C Eisenlohr; Scott A Waldman
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

7.  Phenotypical and functional analysis of intraepithelial lymphocytes from small intestine of mice in oral tolerance.

Authors:  Maristela Ruberti; Luis Gustavo Romani Fernandes; Patricia Ucelli Simioni; Dirce Lima Gabriel; Aureo Tatsumi Yamada; Wirla Maria da Silva Cunha Tamashiro
Journal:  Clin Dev Immunol       Date:  2012-02-07

8.  An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues.

Authors:  Ronjon Chakraverty; Daniel Côté; Jennifer Buchli; Pete Cotter; Richard Hsu; Guiling Zhao; Teviah Sachs; Costas M Pitsillides; Roderick Bronson; Terry Means; Charles Lin; Megan Sykes
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

9.  CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response.

Authors:  António Peixoto; César Evaristo; Ivana Munitic; Marta Monteiro; Alain Charbit; Benedita Rocha; Henrique Veiga-Fernandes
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

10.  Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment.

Authors:  Jarish N Cohen; Eric F Tewalt; Sherin J Rouhani; Erica L Buonomo; Amber N Bruce; Xiaojiang Xu; Stefan Bekiranov; Yang-Xin Fu; Victor H Engelhard
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.